Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4
Abstract Glioma is the most common primary malignant brain tumor with poor survival and limited therapeutic options. The…
Abstract Glioma is the most common primary malignant brain tumor with poor survival and limited therapeutic options. The…
Identifying candidate drugs effective in the new coronavirus disease 2019 (Covid‐19) is crucial, pending a vaccine against SARS‐CoV2….
Overall, we are the first to show that application of C. sativa extracts profoundly decreases the level of…
In murine models of lung injury, CBD reduced lipopolysaccharide (LPS)-induced acute pulmonary inflammation [41,42]. In rat models of…
Like Δ9-tetrahydrocannabinol (Δ9-THC), the most well-studied cannabinoid, CBD decreased lung inflammation in a murine model of acute lung…
The observed down-regulation of ACE2 gene expression by several tested extracts of C. sativa is a novel and…
Abstract Radiotherapy combined with chemotherapy is the major treatment modality for human glioblastoma multiforme (GBM). GBMs eventually relapse…
Abstract According to recent studies, Cannabidiol (CBD), one of the main components of Cannabis sativa, has anticancer effects in…
Abstract Glioblastoma is the most common primary brain tumor in adults. While the introduction of temozolomide chemotherapy has…
Abstract The main chemical component of cannabis, cannabidiol (CBD), has been shown to have antitumor properties. The present…